Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
293 Leser
Artikel bewerten:
(1)

Docquity Launches Engage, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry

SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- Docquity, a leading health tech company in Asia, today announced the launch of Docquity Engage, an AI and Insights-powered market intelligence engine designed to help life sciences companies better understand and optimize engagements with healthcare professional (HCP) audiences.

Backed by real-world insights from Docquity's network of more than 500,000 verified doctors across Asia, Docquity Engage provides pharmaceutical brand and field teams with real-time visibility into HCP behaviors and preferences, supported by AI-assisted recommendations to enable more effective and measurable campaigns. The launch builds on Docquity's ongoing partnerships with leading life sciences companies that leverage data science to improve HCP engagement.

"Life sciences teams today maintain high levels of online and offline engagement with their HCP audiences, making it increasingly challenging to determine which activities are truly resonating and driving impact," said Michael Clarin, Head of Life Sciences Insights at Docquity. "Engage is designed to help life sciences companies move beyond volume, frequency and activity-based metrics by providing a compliant, automated intelligence engine that integrates HCP insights with clients' customer relationship management (CRM) systems to analyze the context behind audience interactions, enable more targeted and timely outreach at scale and drive tangible ROI per HCP engagement."

Engage has already been deployed in the Philippines with a multinational life sciences company, marking the engine's first commercial deployment in a live production environment.

"The launch of Engage marks an important milestone for Docquity, as we continue to develop technology that helps healthcare professionals access the right knowledge and resources to make more informed decisions in their daily practice," said Amit Vithal, Co-Founder and Chief of Growth at Docquity. "Through its initial deployment, we have seen Docquity Engage support up to an 80% reduction in cost per HCP touchpoint - demonstrable early results that are informing how we continue to refine the engine and build productized adaptors for life sciences CRM platforms."

About Docquity Engage

Docquity Engage is an AI and insights-powered market intelligence engine designed to help life sciences companies make personalized, compliant engagement with healthcare professionals (HCPs) the new standard. By combining real-world insights from Docquity's leading HCP network with enterprise systems within life sciences organizations, Engage enables the industry to move beyond activity-based metrics and gain clearer, automated visibility into engagement effectiveness across channels, backed by audience behavior and prescription intent.

The engine adopts four core mechanisms:

  • Engage Compass: A dynamic segmentation engine that builds unified 360-degree HCP profiles using machine learning and rule-based logic, creating actionable segments for AI-assisted campaigns
  • Engage Signal: An engagement command center that tracks omnichannel activity in real-time, quantifying true reach and frequency, to produce behavioral-based campaign recommendations at the HCP level
  • Engage Dialog: A frontline execution tool that supports field teams by identifying the optimal HCP, channel and timing for each engagement, supported by personalized and compliant messaging scripts
  • Engage Impact(currently in beta): An attribution module that connects engagement activities with measurable outcomes, including behavioral change indicators and intent-based signals, to support more informed campaigns

Cision View original content:https://www.prnewswire.co.uk/news-releases/docquity-launches-engage-an-ai-and-insights-powered-hcp-intelligence-engine-for-the-life-sciences-industry-302661037.html

© 2026 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.